Sudhir Srivastava: I consider myself as an early adopter of AI/ML and the technological development in this area

Sudhir Srivastava, Senior Scientific Officer of Cancer Biomarkers Research at National Cancer Institute (NCI), shared in LinkedIn:

“AI/ML has become a buzz word these days. I remember hosting a NCI-sponsored workshop in early 1994 on Computer Applications in Early Detection and Staging of Cancer and the entire proceeding was published in the journal Cancer Letters See below). I consider myself as an early adopter of AI/ML and the technological development in this area. AI/ML is increasingly being used in diagnostic resolution. I am so fortunate to see the revolution in technological advancements in a variety of applications. Let us focus our energy toward fulfilling the dream of early cancer detection and curative treatment.”

Source: Sudhir Srivastava/LinkedIn